Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

ENDRA Life Sciences (NDRA) Non Operating Income (2016 - 2025)

ENDRA Life Sciences has reported Non Operating Income over the past 6 years, most recently at -$341687.0 for Q4 2021.

  • Quarterly Non Operating Income fell 6394.72% to -$341687.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$41545.0 through Dec 2021, down 976.85% year-over-year, with the annual reading at -$1.3 million for FY2025, 83.02% down from the prior year.
  • Non Operating Income was -$341687.0 for Q4 2021 at ENDRA Life Sciences, down from -$7507.0 in the prior quarter.
  • Over five years, Non Operating Income peaked at $676842.0 in Q4 2019 and troughed at -$773029.0 in Q3 2019.
  • The 5-year median for Non Operating Income is -$2055.0 (2019), against an average of -$10117.5.
  • The largest YoY upside for Non Operating Income was 18876.59% in 2018 against a maximum downside of 19994.42% in 2018.
  • A 5-year view of Non Operating Income shows it stood at $1931.0 in 2017, then surged by 18876.59% to $366438.0 in 2018, then surged by 84.71% to $676842.0 in 2019, then plummeted by 100.78% to -$5261.0 in 2020, then tumbled by 6394.72% to -$341687.0 in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Non Operating Income are -$341687.0 (Q4 2021), -$7507.0 (Q3 2021), and $1086.0 (Q2 2021).